| Review: |
The pharmaceutical industry is, arguably, suffering from an innovation deficit as it struggles with new and ever-increasing economic pressures. For the full promises of the last 50 years to be realized, a new approach to drug discovery and development is needed. This book looks at the state-of-the-art, at some of the early success stories, and it gives a strategic analysis of the issues that currently face the drug industry. The authors present the basic principles that underlay modern drug discovery, how they have evolved, and their use in various approaches and strategies. There is a detailed examination of the regulations, requirements, guidelines and draft documents that guide many of the FDA actions. The last part of the book deals with industrialization, the management of research sample collections, information and knowledge management functions, the drug screening process, and ethical issues. |